Abbvie INC (ABBV) Stake Decreased by Cibc World Markets Corp

AbbVie Inc. (NYSE:ABBV) Corporate LogoDuring Q3 2018 the big money sentiment decreased to 0.82. That’s change of 0.12, from 2018Q2’s 0.94. 60 investors sold all, 637 reduced holdings as ABBV ratio is negative. 466 grew holdings while 107 funds amassed holdings. Funds hold 994.12 million shares thus 0.91% less from 2018Q2’s 1.00 billion shares. Bremer Tru Association invested in 0.29% or 12,054 shs. Cornerstone Ltd Company holds 0.07% or 16,640 shs. 13,860 are held by Spectrum Asset (Nb Ca). Park Avenue Securities Ltd Co has invested 0.12% in AbbVie Inc. (NYSE:ABBV). Oppenheimer holds 193,862 shs or 0.47% of its capital. Pettee Invsts reported 1.8% of its capital in AbbVie Inc. (NYSE:ABBV). Leavell Mngmt has invested 0.71% in AbbVie Inc. (NYSE:ABBV). Massmutual Trust Fsb Adv has invested 0% in AbbVie Inc. (NYSE:ABBV). Moreover, Main Street Research Limited has 2.2% invested in AbbVie Inc. (NYSE:ABBV). Thompson Rubinstein Inc Or owns 82,433 shs. First Quadrant LP Ca has 0.1% invested in AbbVie Inc. (NYSE:ABBV) for 47,521 shs. Commerzbank Aktiengesellschaft Fi, a Germany-based fund reported 179,014 shs. 45,672 were accumulated by Winslow Evans & Crocker Inc. Schroder Inv Mgmt Gp reported 2.36M shs stake. Aspen Inv Management invested 0.35% in AbbVie Inc. (NYSE:ABBV).

ABBV registered $21.78 million net activity with 0 buys and 5 sales since August 17, 2018. On Friday, August 17 SEVERINO MICHAEL sold $4.88M worth of AbbVie Inc. (NYSE:ABBV). $8.81M worth of stock was sold by Schumacher Laura J on Tuesday, December 4. On Tuesday, December 11 GONZALEZ RICHARD A sold $1.50 million worth of AbbVie Inc. (NYSE:ABBV). 60,000 shs were sold by CHASE WILLIAM J, worth $5.40M.

Based on the latest 2018Q3 regulatory filing with the SEC, Cibc World Markets Corp reduced its stake in Abbvie Inc (ABBV) by 51.29%. The company’s stock declined 6.62% with the market as Cibc World Markets Corp sold 650,349 shares. The institutional investor is holding 617,574 shares, compared to the 1.27 million from the previous quarter. And the reported value of the major pharmaceuticals company is $58.41M for the 2018Q3. Abbvie Inc has $121.53 billion market cap. ABBV touched $80.79 during the last trading session after $0.86 change.AbbVie Inc. has volume of 4.24M shares. Since February 14, 2018 ABBV has declined 7.04% and is downtrending. ABBV underperformed by 7.04% the S&P500.

The Cibc World Markets Corp’s stake in Valero Energy Corp New Com (NYSE:VLO) was upped by 158,472 shares to 569,343 shares valued at $64.76 million in 2018Q3, according to the filing. It operates about $11.73B US Long portfolio. For a total of 86,978 shares it increased its holding in Becton Dickinson & Co (NYSE:BDX) by 18,266 shares in the quarter, and has risen its stake in Automatic Data Processing I (NASDAQ:ADP).

For more AbbVie Inc. (NYSE:ABBV) news released recently go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “3 Reasons I Just Tripled Down On AbbVie – Seeking Alpha” released on January 28, 2019, “AbbVie: Tough 2019 Ahead – Seeking Alpha” on January 28, 2019, “After Humira: AbbVie’s Upa Vs. Gilead’s Filgo – Seeking Alpha” with a publish date: February 08, 2019, “AbbVie’s Imbruvica flunks late-stage pancreatic cancer study – Seeking Alpha” and the last “FDA OKs new use for AbbVie’s Imbruvica – Seeking Alpha” with publication date: January 28, 2019.

AbbVie Inc. (NYSE:ABBV) Ratings Coverage

Total analysts of 5 have positions in AbbVie (NYSE:ABBV) as follows: 2 rated it a “Buy”, 1 with “Sell” and 2 with “Hold”. The positive are 40%. Since August 22, 2018 according to StockzIntelligence Inc AbbVie has 7 analyst reports. On Monday, November 5 the stock of AbbVie Inc. (NYSE:ABBV) has “Underperform” rating given by BMO Capital Markets. In Tuesday, November 6 report Argus Research maintained the stock with “Buy” rating. On Thursday, January 3 the stock has “Neutral” rating by Bank of America. On Thursday, October 4 the firm earned “Buy” rating by Bank of America. On Wednesday, August 22 the rating was maintained by Bank of America with “Buy”. On Wednesday, January 23 the stock of AbbVie Inc. (NYSE:ABBV) has “Neutral” rating given by UBS.

AbbVie Inc. (NYSE:ABBV) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.